2012
The determinants of tumour immunogenicity.
Blankenstein, T., Coulie, P.G., Gilboa, E. and Jaffee, E.M.
Nature Reviews Cancer 12
(4): 307-313.
April 2012
Targeting MET in cancer: rationale and progress.
Gherardi, E., Birchmeier, W., Birchmeier, C. and Woude, G.V.
Nature Reviews Cancer 12
(2): 89-103.
February 2012
2010
The shunt problem: control of functional shunting in normal and tumour vasculature.
Pries, A.R., Hoepfner, M., le Noble, F., Dewhirst, M.W. and Secomb, T.W.
Nature Reviews Cancer 10
(8): 587-593.
August 2010
2009
The ups and downs of p53: understanding protein dynamics in single cells.
Batchelor, E., Loewer, A. and Lahav, G.
Nature Reviews Cancer 9
(5): 371-377.
May 2009
2008
Wnt signalling and its impact on development and cancer.
Klaus, A. and Birchmeier, W.
Nature Reviews Cancer 8
(5): 387-398.
May 2008
2003
Senescence apoptosis and therapy - cutting the lifelines of cancer.
Schmitt, C.A.
Nature Reviews Cancer 3
(4): 286-295.
April 2003
This list was generated on Sat Dec 21 14:31:56 2024 UTC.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
